BIOADAPTIVES, INC. (BDPT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, BIOADAPTIVES, INC. reported revenue of $18.3K, up 44.3% from the prior year. The company ran a net loss, with a net margin of -8523.4% and a gross margin of 68.4%. It held $225.9K in total assets against $2.36M in total liabilities.
Key ratios (FY2025)
68.4%
Gross margin
-5701.8%
Operating margin
-8523.4%
Net margin
+44.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.3K | $12.7K | $28.6K | $17.2K | $19.8K | $16.3K | $9.9K | — | — | — |
| Cost of Revenue | $5.8K | $8.6K | $17.7K | $10.1K | $9.7K | $10.2K | $5.0K | — | — | — |
| Gross Profit | $12.5K | $4.0K | $10.8K | $7.1K | $10.1K | $6.1K | $4.9K | — | — | — |
| Operating Income | -$1.04M | -$602.1K | -$228.9K | -$421.9K | — | — | — | — | — | -$227.3K |
| Net Income | -$1.56M | -$899.2K | -$712.5K | -$895.6K | -$1.05M | -$847.2K | -$238.9K | -$1.41M | — | -$227.4K |
| EPS (Diluted) | $-0.15 | $-0.11 | — | — | — | — | — | — | — | — |
| Total Assets | $225.9K | $261.9K | $104.0K | $37.3K | $148.6K | $18.8K | $24.2K | $110.1K | — | $7.2K |
| Total Liabilities | $2.36M | $1.73M | $1.75M | $1.49M | $1.24M | $1.40M | $864.1K | $803.8K | — | $210.6K |
| Shareholders' Equity | -$2.13M | -$1.46M | -$1.65M | -$1.45M | -$1.09M | -$1.38M | -$839.9K | -$693.7K | -$3.5K | -$203.4K |
| Cash & Equivalents | $215.2K | $261.9K | $88.6K | $82.9K | $82.9K | $4.6K | $12.3K | $56.2K | — | $99 |
| Operating Cash Flow | -$516.0K | -$249.5K | -$223.8K | -$227.3K | -$158.7K | -$106.9K | -$168.1K | -$420.1K | — | -$72 |
| Capital Expenditures | $18.0K | $0 | — | — | — | — | — | — | — | — |
| Shares Outstanding | 12.01M | 8.22M | 5.97M | 252.55M | 50.82M | 20.83M | 18.58M | 18.10M | — | 12.74M |